01 3Aspaveli/Empaveli
Main Therapeutic Indication : Hematology
Currency : USD
2021 Revenue in Millions : 0
2020 Revenue in Millions : 0
Growth (%) : New Launch in 2021
Main Therapeutic Indication : Hematology
Currency : USD
2022 Revenue in Millions : 17
2021 Revenue in Millions : 0
Growth (%) : >200
Main Therapeutic Indication : Hematology
Currency : USD
2023 Revenue in Millions : 57
2022 Revenue in Millions : 17
Growth (%) : 234
LOOKING FOR A SUPPLIER?
